Detalhe da pesquisa
1.
CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
Biochem Biophys Res Commun
; 548: 148-154, 2021 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33640608
2.
Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line.
J Transl Med
; 17(1): 58, 2019 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30813939
3.
Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
Eur J Med Res
; 29(1): 231, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609993
4.
LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
Life Sci
; 320: 121512, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858312
5.
LncRNA-ZXF1 stabilizes P21 expression in endometrioid endometrial carcinoma by inhibiting ubiquitination-mediated degradation and regulating the miR-378a-3p/PCDHA3 axis.
Mol Oncol
; 16(3): 813-829, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751805
6.
DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.
Cancer Med
; 8(9): 4380-4388, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215145